Kathy Fay Mahdoubi, May 8th, Molecular Imaging, “The current climate of Parkinson’s research is much like it was for Alzheimer’s disease before there was a clear way forward toward pathological detection. Complex clinical features, genetics and molecular drivers of the disease in all its various forms make it exceedingly difficult to standardize research and therefore screening and diagnosis, but a new framework for research is being presented, according to a perspective piece published online April 11 by The Lancet.”